An outside the United States (OUS) clinical trial using gene therapy to reverse age-related diseases, starting with Alzheimer's

Trial Profile

An outside the United States (OUS) clinical trial using gene therapy to reverse age-related diseases, starting with Alzheimer's

Planning
Phase of Trial: Phase I

Latest Information Update: 12 Jan 2018

At a glance

  • Drugs Gene therapies (Primary)
  • Indications Alzheimer's disease
  • Focus Adverse reactions
  • Most Recent Events

    • 12 Jan 2018 New trial record
    • 10 Jan 2018 According to a Libella Gene Therapeutics media release, this trial is expected to begin in the first quarter of 2018 and will be conducted at MediHelp Services Clinic. Dr. Javier Hernandez, MediHelp's medical director, will oversee the trial.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top